BridgeBio Pharma, Inc. (BBIO) Social Stream
BridgeBio Pharma Inc (BBIO) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BBIO.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 10 | $91 | $66 | $80.4 | $48.73 | 64.99% |
The Trend in the Analyst Price Target
Over the past 16 months, BBIO's average price target has gone up $35.5.
BBIO reports an average of 26.04% for its upside potential over the past 16 months.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-11 | 10 | 91 | 66 | 80.40 | 50.35 | 59.68% |
| 2021-09-04 | 9 | 91 | 66 | 80.44 | 51.62 | 55.83% |
| 2021-08-28 | 8 | 91 | 66 | 80.88 | 50.48 | 60.22% |
| 2021-08-14 | 8 | 91 | 66 | 80.88 | 50.12 | 61.37% |
| 2021-08-07 | 8 | 91 | 66 | 80.88 | 54.10 | 49.5% |
| 2021-08-05 | 8 | 91 | 71 | 81.63 | 56.13 | 45.43% |
| 2021-08-01 | 8 | 91 | 71 | 81.63 | 53.45 | 52.72% |
| 2021-07-24 | 8 | 91 | 71 | 81.63 | 60.60 | 34.7% |
| 2021-07-17 | 8 | 91 | 71 | 81.63 | 59.18 | 37.94% |
| 2021-07-10 | 8 | 91 | 71 | 81.63 | 64.17 | 27.21% |
| 2021-07-03 | 8 | 91 | 71 | 81.63 | 63.85 | 27.85% |
| 2021-06-26 | 8 | 91 | 71 | 81.63 | 60.45 | 35.04% |
| 2021-06-13 | 8 | 91 | 71 | 81.63 | 63.93 | 27.69% |
| 2021-06-05 | 8 | 91 | 71 | 81.63 | 57.96 | 40.84% |
| 2021-05-22 | 8 | 91 | 71 | 81.63 | 57.90 | 40.98% |
| 2021-05-15 | 8 | 91 | 71 | 81.63 | 53.66 | 52.12% |
| 2021-05-08 | 8 | 92 | 71 | 83.13 | 48.03 | 73.08% |
| 2021-04-25 | 8 | 92 | 75 | 84.25 | 54.47 | 54.67% |
| 2021-04-17 | 8 | 91 | 75 | 84.13 | 55.12 | 52.63% |
| 2021-04-10 | 9 | 91 | 75 | 84.22 | 54.49 | 54.56% |
| 2021-04-03 | 9 | 91 | 75 | 84.22 | 59.36 | 41.88% |
| 2021-03-20 | 9 | 91 | 67 | 81.67 | 67.66 | 20.71% |
| 2021-03-13 | 9 | 91 | 67 | 81.67 | 70.94 | 15.13% |
| 2021-03-06 | 9 | 91 | 67 | 81.67 | 62.22 | 31.26% |
| 2021-02-27 | 9 | 91 | 56 | 78.33 | 70.68 | 10.82% |
| 2021-02-20 | 9 | 91 | 50 | 71.22 | 66.68 | 6.81% |
| 2021-02-13 | 9 | 91 | 50 | 71.22 | 67.36 | 5.73% |
| 2021-02-06 | 8 | 91 | 50 | 69.75 | 68.28 | 2.15% |
| 2021-01-30 | 8 | 91 | 50 | 69.75 | 56.76 | 22.89% |
| 2021-01-23 | 8 | 91 | 44 | 63.75 | 69.48 | -8.25% |
| 2021-01-16 | 8 | 91 | 44 | 63.75 | 68.61 | -7.08% |
| 2021-01-09 | 8 | 91 | 44 | 60.88 | 65.51 | -7.07% |
| 2021-01-02 | 9 | 91 | 44 | 56.11 | 71.11 | -21.09% |
| 2020-12-26 | 9 | 91 | 44 | 56.11 | 69.50 | -19.27% |
| 2020-12-19 | 9 | 91 | 44 | 56.11 | 64.89 | -13.53% |
| 2020-12-10 | 9 | 60 | 44 | 50.22 | 57.75 | -13.04% |
| 2020-12-07 | 9 | 60 | 44 | 50.22 | 53.10 | -5.42% |
| 2020-11-28 | 9 | 60 | 39 | 49.11 | 49.13 | -0.04% |
| 2020-11-11 | 9 | 60 | 39 | 49.11 | 40.97 | 19.87% |
| 2020-10-09 | 9 | 53 | 39 | 46.78 | 39.34 | 18.91% |
| 2020-09-29 | 11 | 52 | 38 | 45.27 | 37.10 | 22.02% |
| 2020-08-11 | 11 | 51 | 38 | 44.45 | NA | NA% |
| 2020-07-28 | 11 | 51 | 38 | 44.27 | NA | NA% |
| 2020-07-22 | 11 | 51 | 38 | 44.27 | NA | NA% |
| 2020-06-25 | 11 | 51 | 38 | 44.27 | NA | NA% |
| 2020-05-29 | 10 | 51 | 39 | 44.90 | NA | NA% |
BBIO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.28 | 4 | 5 | 0 | 0 | 0 | 9 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- The average analyst price target of BBIO is higher than 90.21% of Pharmaceutical Products stocks.
- The upside potential (average analyst target price relative to current price) of BBIO is greater than 87.06% of stocks in the mid market cap category.
- The number of analysts covering the stock of BBIO is greater than 86.15% of Pharmaceutical Products stocks.
- BridgeBio Pharma Inc's variance in analysts' estimates is less than 64.06% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, REPL, IGMS and ITCI are the three stocks most similar to BridgeBio Pharma Inc regarding the price target and analyst recommendation information presented here.
Make investment decisions regarding BBIO using the data that counts. Try POWR Ratings for free.